155 related articles for article (PubMed ID: 33328250)
1. Correspondence on 'Jan Gösta Waldenström and rheumatology'.
Moutsopoulos HM
Ann Rheum Dis; 2023 Mar; 82(3):e59. PubMed ID: 33328250
[No Abstract] [Full Text] [Related]
2. Response to: 'Correspondence on 'Jan Gösta Waldenströmand rheumatology'' by Moutsopoulos.
Wollheim FA
Ann Rheum Dis; 2023 Mar; 82(3):e60. PubMed ID: 33328251
[No Abstract] [Full Text] [Related]
3. [Sjogren's syndrome and Sjogren's disease in rheumatology].
Nasonova V; Vasiljev V
Z Gesamte Inn Med; 1981 Mar; 36(6):199-203. PubMed ID: 6973248
[No Abstract] [Full Text] [Related]
4. Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria'.
Tang Z; Shi H; Liu HL; Cheng X; Ye J; Su Y; Hu Q; Meng J; Pan H; Yang C; Teng J; Liu T
Ann Rheum Dis; 2024 Feb; 83(3):e4. PubMed ID: 37989549
[No Abstract] [Full Text] [Related]
5. Lymphoproliferation in autoimmunity and Sjögren's syndrome.
Voulgarelis M; Moutsopoulos HM
Curr Rheumatol Rep; 2003 Aug; 5(4):317-23. PubMed ID: 14531960
[TBL] [Abstract][Full Text] [Related]
6. Clinical associations and expression pattern of the autoimmunity susceptibility factor DIORA-1 in patients with primary Sjögren's syndrome.
Aqrawi LA; Mentlein L; Meneghel L; Björk A; Thorlacius GE; Ivanchenko M; Ramírez Sepúlveda JI; Skarstein K; Kvarnström M; Brauner S; Espinosa A; Wahren-Herlenius M
Ann Rheum Dis; 2018 Dec; 77(12):1840-1842. PubMed ID: 30018071
[No Abstract] [Full Text] [Related]
7. Therapeutic potential for B-cell modulation in Sjögren's syndrome.
Mariette X
Rheum Dis Clin North Am; 2008 Nov; 34(4):1025-33, x. PubMed ID: 18984420
[TBL] [Abstract][Full Text] [Related]
8. Polarization of B effector cells in Sjögren's syndrome.
Daridon C; Guerrier T; Devauchelle V; Saraux A; Pers JO; Youinou P
Autoimmun Rev; 2007 Aug; 6(7):427-31. PubMed ID: 17643928
[TBL] [Abstract][Full Text] [Related]
9. American College of Rheumatology/European League Against Rheumatism Sjögren's Syndrome Classification Criteria May Not Be Adequate for Extraglandular Disease and Necessitate Defining "Seronegative Sjögren's Syndrome": Comment on the Article by Shiboski et al.
Tezcan ME; Kucuk H; Goker B
Arthritis Rheumatol; 2017 Jun; 69(6):1341-1342. PubMed ID: 28245349
[No Abstract] [Full Text] [Related]
10. Sjögren's syndrome: a human model of autoimmunity and malignancy.
Moutsopoulos HM; Andonopoulos AP
Br J Rheumatol; 1988 Aug; 27(4):253-7. PubMed ID: 3261607
[No Abstract] [Full Text] [Related]
11. Role of interaction between B cells and epithelial cells in pSS.
Pringle S; Verstappen GM; Bootsma H; Kroese FGM
Ann Rheum Dis; 2022 Dec; 81(12):e260. PubMed ID: 33060075
[No Abstract] [Full Text] [Related]
12. Correspondence on "ACR/EULAR antiphospholipid syndrome classification criteria".
Damoiseaux J; van Beers J
Ann Rheum Dis; 2024 Feb; 83(3):e6. PubMed ID: 37989546
[No Abstract] [Full Text] [Related]
13. Primary Sjögren's syndrome and deficiency of ICA69.
Winer S; Astsaturov I; Cheung R; Tsui H; Song A; Gaedigk R; Winer D; Sampson A; McKerlie C; Bookman A; Dosch HM
Lancet; 2002 Oct; 360(9339):1063-9. PubMed ID: 12383988
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities of B cell phenotype, immunoglobulin gene expression and the emergence of autoimmunity in Sjögren's syndrome.
Dörner T; Lipsky PE
Arthritis Res; 2002; 4(6):360-71. PubMed ID: 12453312
[TBL] [Abstract][Full Text] [Related]
15. Henrik Sjögren (1899-1986): the syndrome and his legacy.
Jonsson R
Ann Rheum Dis; 2021 Sep; 80(9):1108-1109. PubMed ID: 34385154
[No Abstract] [Full Text] [Related]
16. Diagnosis of Sjögren's syndrome: American-European and the American College of Rheumatology classification criteria.
Sankar V; Noll JL; Brennan MT
Oral Maxillofac Surg Clin North Am; 2014 Feb; 26(1):13-22. PubMed ID: 24287190
[TBL] [Abstract][Full Text] [Related]
17. Autoantigen
Hillen MR; Urso K; Koppe E; Lopes AP; Blokland SLM; Pandit A; Slocombe T; van Maurik A; van Roon JAG; Radstake TRDJ
RMD Open; 2020 Jun; 6(2):. PubMed ID: 32540951
[No Abstract] [Full Text] [Related]
18. Role of B cells in Sjögren's syndrome--from benign lymphoproliferation to overt malignancy.
Jonsson R; Nginamau E; Szyszko E; Brokstad KA
Front Biosci; 2007 Jan; 12():2159-70. PubMed ID: 17127453
[TBL] [Abstract][Full Text] [Related]
19. Not all autoantibodies are clinically relevant. Classic and novel autoantibodies in Sjögren's syndrome: A critical review.
Vílchez-Oya F; Balastegui Martin H; García-Martínez E; Corominas H
Front Immunol; 2022; 13():1003054. PubMed ID: 36325321
[TBL] [Abstract][Full Text] [Related]
20. Response to: Correspondence on '2023 ACR/EULAR antiphospholipid syndrome classification criteria' by Tang
Barbhaiya M; Zuily S; Hendry AM; Manneville F; Guillemin F; Costenbader KH; Erkan D
Ann Rheum Dis; 2024 Feb; 83(3):e5. PubMed ID: 37989547
[No Abstract] [Full Text] [Related]
[Next] [New Search]
